Allakos has a chemical that targets a market that is largely undiagnosed. If their prevalence data is accurate, the therapy’s potential is enormous. Continue reading
Allakos: Prevalence Data Shows A Large Undiagnosed Market (NASDAQ:ALLK)
2021-06-29T12:35:55-04:00June 29th, 2021|